Rochemexico vs Glenmark-pharmaceuticals - Cyber Risk Comparison & Security Rating

Comparison Overview

Roche México

VS

Glenmark Pharmaceuticals

Roche México

Cerrada de Bezares 9, col. Lomas de Bezares, Ciudad de México, 11910, MX

Last Update: 19/03/2026

View Profile

Between 750 and 799

http://www.roche.com.mx

757/1000Fair

Llevamos 75 años siendo líderes en el campo de la salud en México. Creamos, producimos y comercializamos soluciones innovadoras de alta calidad para satisfacer necesidades médicas no cubiertas. Nuestros productos y servicios contribuyen a la prevención, el diagnóstico...

NAICS:3254

NAICS Definition:Pharmaceutical and Medicine Manufacturing

Employees:355

Subsidiaries:51

12-month incidents

0

Known data breaches

0

Attack type number

0

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099

Last Update: 29/04/2026

View Profile

Between 600 and 649

http://www.glenmarkpharma.com

639/1000Poor

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...

NAICS:3254

NAICS Definition:Pharmaceutical and Medicine Manufacturing

Employees:14,777

Subsidiaries:0

12-month incidents

1

Known data breaches

0

Attack type number

1

Compliance Ranges Comparison

Based On Specific Ai Models Category

Roche México

-

ISO 27001Not verified

-

SOC2 Type 1Not verified

-

SOC2 Type 2Not verified

-

GDPRNot verified

-

PCI DSSNot verified

-

HIPAANot verified

Glenmark Pharmaceuticals

-

ISO 27001Not verified

-

SOC2 Type 1Not verified

-

SOC2 Type 2Not verified

-

GDPRNot verified

-

PCI DSSNot verified

-

HIPAANot verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Roche México in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Glenmark Pharmaceuticals has 3.85% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Roche México (X = Date, Y = Severity)

Roche México cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available

R - Ransomware

C - Cyber Attack

D - Data Breach

V - Vulnerability

Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware

C - Cyber Attack

D - Data Breach

V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...

Roche México

Incidents

No explicit notable incidents reported.

Glenmark Pharmaceuticals

Incidents

🔒 Incident : Ransomware

KOPGLE1777473227

FAQ

Between Roche México company and Glenmark Pharmaceuticals company, which one has the best AI Cybersecurity Score ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents in the past ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents this year ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has experienced at least one ransomware attack ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has experienced at least one data breach ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has experienced at least one vulnerability ?

Between Roche México company and Glenmark Pharmaceuticals company, which one holds the most compliance certifications ?

Between Roche México company and Glenmark Pharmaceuticals company, which one holds the fewest compliance certifications ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has the most subsidiaries ?

Between Roche México company and Glenmark Pharmaceuticals company, which one has the largest number of employees ?

Between Roche México and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?

Between Roche México and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?

Which company is ISO 27001 certified - Roche México or Glenmark Pharmaceuticals ?

Which company is PCI DSS compliant - Roche México or Glenmark Pharmaceuticals ?

Between Roche México and Glenmark Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?

Between Roche México and Glenmark Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246

SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED

Date2026-07-22

UPDATED

Date2026-07-22

RISK INFORMATION (Score: 8.8)

CVSS3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

IMPACT SCORE

5.9

EXPLOITABILITY

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60455

SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED

Date2026-07-22

UPDATED

Date2026-07-22

RISK INFORMATION (Score: 8.8)

CVSS3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

IMPACT SCORE

5.9

EXPLOITABILITY

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60439

SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED

Date2026-07-22

UPDATED

Date2026-07-22

RISK INFORMATION (Score: 8.8)

CVSS3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

IMPACT SCORE

5.9

EXPLOITABILITY

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60373

SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED

Date2026-07-22

UPDATED

Date2026-07-22

RISK INFORMATION (Score: 8.8)

CVSS3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

IMPACT SCORE

5.9

EXPLOITABILITY

2.8

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html

CVE-2026-60372

SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED

Date2026-07-22

UPDATED

Date2026-07-22

RISK INFORMATION (Score: 9.8)

CVSS3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

IMPACT SCORE

5.9

EXPLOITABILITY

3.9

REFERENCES

https://www.oracle.com/security-alerts/cpujul2026.html